Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
Completed · Phase 2 · Has a placebo group
Conditions studied: Diabetes Mellitus, Type 2
In brief
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on fasting plasma glucose (FPG).
Key facts
- Study ID
- NCT01111955
- Run by
- Bristol-Myers Squibb
- People needed
- 62
- Starts
- 2010-07-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2015-10-12
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 diabetes mellitus
- Drug naive or on stable metformin therapy
- HbA1c 7-10%
- FPG ≤ 240mg/dL
You may not qualify if…
- History of myocardial infarction, coronary angioplasty or bypass grafts, valvular disease or repair, unstable angina pectoris, transient ischemic attack, or cerebrovascular accidents within six months prior to entry into the study
- Congestive heart failure
- Active liver disease
- Impaired renal function
- Hepatitis C, B and HIV
- This list is not inclusive; additional information is provided in the protocol
Where it is running
- Farid Marquez, Md — Hialeah, Florida, United States
- Capital Clinical Reserch Center — Olympia, Washington, United States
- Aurora Advanced Healthcare — Milwaukee, Wisconsin, United States
- Local Institution — Blacktown, New South Wales, Australia
- Local Institution — Box Hill, Victoria, Australia
- Local Institution — Freemantle, Western Australia, Australia
- Local Institution — Surrey, British Columbia, Canada
- Local Institution — Winnipeg, Manitoba, Canada
- Local Institution — Bathurst, New Brunswick, Canada
- Local Institution — St. John's, Newfoundland and Labrador, Canada
- Local Institution — Thornhill, Ontario, Canada
- Local Institution — Mirabel, Quebec, Canada
- Local Institution — Québec, Quebec, Canada
- Local Institution — Saskatoon, Saskatchewan, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.